Michael Sefton (left), scientific director of Medicine by Design and University Professor at the University of Toronto (U of T) (Photo by Neil Ta). Bradly Wouters (right), executive VP, science and research, University Health Network (UHN) and professor at U of T (Photo provided by UHN).

Canada is a world-leader in advanced life sciences research including regenerative medicine. But when it comes to turning that research into health innovation, Canada lags other countries. Canadians could cure diseases like type 1 diabetes —we just need the ambition to do it.

Read more in an op-ed published in The Toronto Star by Medicine by Design’s Michael Sefton, scientific director, and University Health Network’s Bradly Wouters, executive VP, science and research.